Publications by authors named "Anna de Daniel"

Claim this Profile
B
Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited.
Luis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol, Anthony M Battram, Sergi Vaqué-Salsench, Anna de Daniel

Cancer Immunol Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond L265P.
David F Moreno, Ferran Nadeu, Fara Brasó-Maristany, Sergi Vaqué, Sara Paz, Anna de Daniel

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attrition rates and treatment outcomes in multiple myeloma: real-world data over a 40-year period.
Luis Gerardo Rodríguez-Lobato, Anna de Daniel, Arturo Pereira, Carlos Fernández de Larrea, Natalia Tovar, Daniel Munárriz

Blood Cancer J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma.
Anna de Daniel, Luis Gerardo Rodríguez-Lobato, Natalia Tovar, M Teresa Cibeira, David F Moreno

Hemasphere· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution.
Luis Gerardo Rodríguez-Lobato, Natalia Tovar, Anna de Daniel, Carlos Fernández de Larrea, M Teresa Cibeira

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis